Statin therapy in heart failure

Expert Review of Cardiovascular Therapy

Volumn 3, Issue 1, 2005, Pages 5-7

  Soaly, Ezeldin ^a   Al Suwaidi, Jassim ^a  

^a HAMAD GENERAL HOSPITAL   (Qatar)

Author keywords

[No Author keywords available]

Indexed keywords

AMLODIPINE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BISOPROLOL; CERIVASTATIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOSARTAN; SIMVASTATIN; VALSARTAN;

CARDIOMYOPATHY; CARDIOVASCULAR RESPONSE; CLINICAL TRIAL; CONGESTIVE CARDIOMYOPATHY; CONGESTIVE HEART FAILURE; CORONARY ARTERY DISEASE; DRUG COST; DRUG MECHANISM; EDITORIAL; EVIDENCE BASED MEDICINE; HEART FAILURE; HEART INFARCTION; HEART LEFT VENTRICLE HYPERTROPHY; HUMAN; ISCHEMIC HEART DISEASE; MORTALITY; NONHUMAN; OUTCOMES RESEARCH; PATHOPHYSIOLOGY; PROGNOSIS; RECURRENT DISEASE; RISK REDUCTION; SURVIVAL RATE;

ANIMALS; ANTILIPEMIC AGENTS; HEART FAILURE, CONGESTIVE; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; RANDOMIZED CONTROLLED TRIALS;

EID: 12444283795     PISSN: 14779072     EISSN: None     Source Type: Journal    
DOI: 10.1586/14779072.3.1.5     Document Type: Editorial

References (11)

1. Krum H, McMurray JJ. Statins and chronic heart failure: do we need a large-scale outcome tiral? J. Am. Coll. Cardiol. 39, 1567-1573 (2002).
2. Chen MS, Xu FP, Wang YZ et al. Statins initiated after hypertohy inhibit oxidative stress and prevent heart failure in rats with aortic stenosis. J. Mol. Cell. Cardiol. 37, 889-896 (2004).
3. Kjekshus JK, Pedersen TR, Olsson AG, Faergeman O, Pyorälä K. The effects of simvastatin on the incidence of heart failure with coronary heart disease. J. Card. Fail. 3, 249-254 (1997).
4. Kjekshus JK. Debate: statins should be used in patients with heart failure. Curr. Control. Trials Cardiovasc. Med. 2, 268-270 (2001).
5. Latini R, Maggioni AP, Anand IS et al. Statins in symptomatic chronic systolic heart failure. A post hoc analysis of 5010 patients enrolled in Val-HeFF. Eur. Heart J. 25 (2004) (Abstract 1473).
6. Krum H, Bailey M, Meyer W et al. Impact of statin therapy on clinical outcomes in CHF patients according to β-blocker use: results of CIBIS. Eur. Heart J. 25 (2004) (Abstract 1474).
7. Noda K, Fujita M, Kitazkaze M et al. Short-term statin therapy improves cardiac function in patients with idiopathic dilated cardiomyopathy. Circulation 108, 839-843 (2003).
8. Horwich TB, MacLellan R, Fonarow GC. Statin therapy associated with improved survival in ischemic and nonischemic heart failure. J. Am. Coll. Cardiol. 43, 642-648 (2004).
9. Mozaffarian D, Nye R, Levy WC. Statin therapy is associated with lower mortality among patients with severe heart failure. Am. J. Cardiol. 93, 1124-1129 (2004).
10. Laufs U, Wassmann S, Schackmann S, Heeschen C, Bohm M, Nickenig G. Beneficial effects of statins in patients with nonischemic heart failure. Z. Kardiol. 93, 103-108 (2004).
11. Prasad A, Higano ST, Al Suwaidi J et al. Coronary microvascular endothelial dysfunction in humans with asymptomatic heart failure. Am. Heart J. 146(3), 549-554 (2003).